World FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis – Contract Pharma Last updated: April 14, 2026 9:31 pm Editorial Staff 2 months ago Share SHARE FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis Contract Pharmasource Prime Minister and Minister of Foreign Affairs Receives Phone Call from Foreign Minister of Armenia – Qatar news agency Germany's Ruling Coalition at Odds Over Reform Push – U.S. News & World Report Trump threat ‘shows desperation’: Iran’s president – The Mercury ‘The question isn’t military victory, it’s what comes next’: US-Iran conflict explained – Sky News Australia The Iran war should boost security cooperation by US Pacific allies like Japan, the Philippines and South Korea – Chatham House Share This Article Facebook Email Print Previous Article Trump again rejects Colorado amid accusations of playing politics with disaster aid – Newsday Next Article Times Opinion: Vaccine confusion sets up US for a resurgence of hepatitis B in babies – Chattanooga Times Free Press Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
